Literature DB >> 26961483

MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer.

Chenglong Li, Li Deng, Qiaoming Zhi, Qingyou Meng, Aimin Qian, Hongfei Sang, Xiaoqiang Li, Jiazeng Xia1.   

Abstract

MicroRNA-183 (miR-183) has recently been identified to be implicated in a variety of critical processes in multiple human malignancies, and its fuction has been poorly characterized in gastric cancer (GC). Here we reported that miR-183 was markedly over-expressed in GC and its up-regulation was markedly associated with GC clinicopathologicalcharacters. Endogenous miR-183 was inhibited in GC cells, which dramatically attenuated cell proliferation, colony formation, migration, invasion and adhesion and enhancedGC cells apoptosis in vitro. Furthermore, in this study we demonstrated that the tumor suppressor gene PDCD4 was a target of miR-183 in GC. Collectively, these observations showed that miR-183 maybe function as an oncogene by regulating GC cell proliferation, apoptosis and metastasis and the oncogenic effect of miR-183 may relate the direct targeting PDCD4.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26961483     DOI: 10.2174/1871520615666150914114237

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  13 in total

1.  Programmed cell death factor 4 enhances the chemosensitivity of colorectal cancer cells to Taxol.

Authors:  Daqing Wang; Qianqian Hou; Lingjun Zhao; Jun Gao; Yang Xiao; Anhua Wang
Journal:  Oncol Lett       Date:  2019-05-27       Impact factor: 2.967

Review 2.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

3.  MicroRNA-183 promotes the proliferation and metastasis of renal cell carcinoma through targeting Dickkopf-related protein 3.

Authors:  Xiao-Long Zhang; Gang Xu; Yi Zhou; Jia-Jun Yan
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

4.  Combined Analysis of ChIP Sequencing and Gene Expression Dataset in Breast Cancer.

Authors:  Pengfei Liu; Wenhua Jiang; Shiyong Zhou; Jun Gao; Huilai Zhang
Journal:  Pathol Oncol Res       Date:  2016-09-21       Impact factor: 3.201

5.  Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis.

Authors:  Jia-Min Gao; Lin-Zhen Huang; Zhi-Guang Huang; Rong-Quan He
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

6.  LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12.

Authors:  Jun Zhang; Hai-Yan Piao; Shuai Guo; Yue Wang; Tao Zhang; Zhi-Chao Zheng; Yan Zhao
Journal:  Int J Clin Oncol       Date:  2020-01-01       Impact factor: 3.402

7.  Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.

Authors:  Rui Zhang; Tian Xia
Journal:  Int J Oncol       Date:  2017-09-19       Impact factor: 5.650

8.  miR-183 modulated cell proliferation and apoptosis in ovarian cancer through the TGF-β/Smad4 signaling pathway.

Authors:  Junhui Zhou; Caixia Zhang; Bo Zhou; Daqiong Jiang
Journal:  Int J Mol Med       Date:  2019-01-29       Impact factor: 4.101

9.  miRNA‑183‑5p.1 promotes the migration and invasion of gastric cancer AGS cells by targeting TPM1.

Authors:  Jun Lin; Juan Shen; Hao Yue; Zhongwei Cao
Journal:  Oncol Rep       Date:  2019-10-04       Impact factor: 3.906

10.  The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p.

Authors:  Xi Lan; Nan Wu; Litao Wu; Kai Qu; Ezra Kombo Osoro; Dongxian Guan; Xiaojuan Du; Bo Wang; Sifan Chen; Ji Miao; Juan Ren; Li Liu; Haiyun Li; Qilan Ning; Dongmin Li; Shemin Lu
Journal:  Mol Ther Nucleic Acids       Date:  2020-03-20       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.